Related Experiment Video
Updated: Jul 28, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
[Cardiac troponin I determination in patients with chronic renal failure]
L M Flores1, J L Hernández Dominguez, A Otero
1Servicio de Análisis Clínicos, Complejo Hospitalario de Ourense, Universitario de Santiago de Compostela.
Insights
Cardiac troponin I (cTnI) is a preferred biomarker for myocardial damage in chronic renal failure (CRF) patients. Adjusting the cTnI cut-off value may improve acute myocardial injury diagnosis in this population.
Area of Science:
- Cardiology
- Nephrology
- Biomarker analysis
Context:
- Chronic renal failure (CRF) presents diagnostic challenges for myocardial injury.
- Standard biomarkers may be affected by renal dysfunction.
- Accurate diagnosis of acute myocardial injury (AMI) is critical in CRF patients.
Purpose:
- To evaluate cardiac troponin I (cTnI) determination in patients with chronic renal failure (CRF).
- To compare cTnI with creatine kinase-MB isoenzyme (CK-MB) for diagnosing myocardial injury.
- To assess the diagnostic performance of cTnI in CRF patients.
Summary:
- A retrospective study analyzed cTnI levels in CRF patients with suspected myocardial injury.
- cTnI diagnosed AMI in 10% of patients (cut-off > 0.05 ng/mL).
- Sensitivity was 70% and specificity 92% for cTnI with a cut-off > 0.5 ng/mL, with 31% false positives.
Impact:
- cTnI is identified as the preferred biomarker for myocardial damage in CRF.
- Findings suggest that alternative cut-off values for cTnI could enhance AMI detection.
- This research aids in refining diagnostic strategies for cardiac events in renal disease.
Objective:
The aim of the study was evaluate cardiac troponin I (cTnI) determination in patients with chronic renal failure (CRF) and compare with creatine kinase-MB isoenzyme (CK-MB and CK-MB/CK).
Methods:
We performed a retrospective study on patients with CRF with MDRD (modification of diet in renal disease study group) < 60 mL/min admitted with suspected myocardial injury by history, physical examination and electrocardiography. cTnI measurement was assessed at admission with the ACCESS analyzer (Beckman).
Results:
Acute myocardial injury (AMI) was diagnosed in 10% (47/467) patients with cTnI determination > 0.05 ng/mL, while the diagnostic was angina in 9% (41/467) and in 81% (379/467) we finded other diagnostics. In the AMI group, 49% had chest discomfort, 43% diabetes and the mortality was 45%, while in the angina group were 41%, 32% and 7%, respectively. The sensitivity for cTnI with cut-off value > 0.5 ng/mL was 70% and specificity 92%. The number of false positives was 31% (20 patients).
Discussion:
cTnI is the preferred biomarker for myocardial damage in patients with CRF. Other cut-off value could enhance the sensitivity for AMI.
More Related Videos
09:23Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management